.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Fish and Richardson
Deloitte
Cantor Fitzgerald
Queensland Health
Baxter
UBS
Mallinckrodt
Merck

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021434

« Back to Dashboard
NDA 021434 describes XANAX XR, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from three suppliers. Additional details are available on the XANAX XR profile page.

The generic ingredient in XANAX XR is alprazolam. There are fifteen drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the alprazolam profile page.

Summary for 021434

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 021434

Ingredient-typeBenzodiazepines

Medical Subject Heading (MeSH) Categories for 021434

Suppliers and Packaging for NDA: 021434

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL 021434 NDA Pharmacia and Upjohn Company LLC 0009-0057 0009-0057-07 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0057-07)
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL 021434 NDA Pharmacia and Upjohn Company LLC 0009-0059 0009-0059-07 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0059-07)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength0.5MG
Approval Date:Jan 17, 2003TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength1MG
Approval Date:Jan 17, 2003TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength2MG
Approval Date:Jan 17, 2003TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 021434

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-001Jan 17, 2003► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-004Jan 17, 2003► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-003Jan 17, 2003► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-002Jan 17, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Cantor Fitzgerald
Merck
Teva
Covington
Healthtrust
Federal Trade Commission
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot